These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 952578)

  • 1. Intravenous pharmacokinetic profile in rats of etomidate, a short-acting hypnotic drug.
    Lewi PJ; Heykants JJ; Janssen PA
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):72-85. PubMed ID: 952578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution, metabolism and excretion of etomidate, a short-acting hypnotic drug, in the rat. Comparative study of (R)-(+)-(--)-Etomidate.
    Heykants JJ; Meuldermans WE; Michiels LJ; Lewi PJ; Janssen PA
    Arch Int Pharmacodyn Ther; 1975 Jul; 216(1):113-29. PubMed ID: 1164098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic data analysis of alfentanil after multiple injections and etomidate-infusion in patients undergoing orthopedic surgery.
    Richter O; Klatte A; Abel J; Freye E; Haag W; Hartung E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):11-5. PubMed ID: 3921471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of etomidate in surgical patients.
    de Ruiter G; Popescu DT; de Boer AG; Smeekens JB; Breimer DD
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):180-8. PubMed ID: 7224720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etomidate, a potent non-barbiturate hypnotic. Intravenous etomidate in mice, rats, guinea-pigs, rabbits and dogs.
    Janssen PA; Niemegeers CJ; Marsboom RP
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):92 -132. PubMed ID: 1156027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of the EEG and pharmacodynamic modelling of hypnotic drugs: etomidate as an example.
    Schwilden H; Schüttler J; Stoeckel H
    Eur J Anaesthesiol; 1985 Jun; 2(2):121-31. PubMed ID: 4029126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the two-compartment open model with Michaelis-Menten elimination kinetics to valproic acid in the bile-exteriorized rat.
    Lawyer CH; Gerber N; Lynn RK; Dickinson RG
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):469-84. PubMed ID: 6770426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion strategies to investigate the pharmacokinetics and pharmacodynamics of hypnotic drugs: etomidate as an example.
    Schüttler J; Schwilden H; Stoeckel H
    Eur J Anaesthesiol; 1985 Jun; 2(2):133-42. PubMed ID: 4029127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of etomidate in man (author's transl)].
    Schüttler J; Wilms M; Lauven PM; Stoeckel H; Koenig A
    Anaesthesist; 1980 Dec; 29(12):658-61. PubMed ID: 7212248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal, oral and I.A. administration of etomidate to rats: significant avoidance of hepatic first-pass elimination following rectal administration.
    de Boer AG; Breimer DD
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):180-91. PubMed ID: 6548357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of zopiclone.
    Gaillot J; Heusse D; Hougton GW; Marc Aurele J; Dreyfus JF
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():76-91. PubMed ID: 7188377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of etomidate in cats.
    Wertz EM; Benson GJ; Thurmon JC; Tranquilli WJ; Davis LE; Koritz GD
    Am J Vet Res; 1990 Feb; 51(2):281-5. PubMed ID: 2301840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat.
    Lettieri JT; Fung HL
    J Pharmacol Exp Ther; 1979 Jan; 208(1):7-11. PubMed ID: 759616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetic profile of ochratoxin A in the rat after oral and intravenous administration.
    Galtier P; Charpenteau JL; Alvinerie M; Labouche C
    Drug Metab Dispos; 1979; 7(6):429-34. PubMed ID: 43233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition kinetics of ketamine in the domestic cat.
    Baggot JD; Blake JW
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):115-24. PubMed ID: 952572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination.
    Fisher DM; Canfell PC; Fahey MR; Rosen JI; Rupp SM; Sheiner LB; Miller RD
    Anesthesiology; 1986 Jul; 65(1):6-12. PubMed ID: 3755306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infusion model for etomidate (author's transl)].
    Schüttler J; Stoeckel H; Wilms M; Schwilden H; Lauven PM
    Anaesthesist; 1980 Dec; 29(12):662-6. PubMed ID: 7212249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat.
    Garrigou-Gadenne D; Burke JT; Durand A; Depoortere H; Thénot JP; Morselli PL
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1283-8. PubMed ID: 2703975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.